Skip to main content
SpringerLink
Log in

Lipid Metabolism and its Disorders in Diabetes Mellitus

  • Chapter
Diabetes and Atherosclerosis

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 125))

  • 78 Accesses

Abstract

It has been known for a long time that there are major disturbances in lipid metabolism in diabetes [1]. Also it is well established that there is a greatly increased incidence of atherosclerotic vascular disease in diabetes (Chapter 4). However, it still remains uncertain to what extent lipoprotein abnormalities contribute to this excess atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Joslin EP (1927) Arteriosclerosis and Diabetes. Ann Clin Med 5:1061–80.

    Google Scholar 

  2. Gibbons GF (1986) Hyperlipidaemia of diabetes. Clin Sci 71:477–86

    PubMed  CAS  Google Scholar 

  3. Howard BV (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613–28

    PubMed  CAS  Google Scholar 

  4. Kissebah AH, Schectman G (1987) Hormones and lipoprotein metabolism. Baillière’s Clinical Endocrinology and Metabolism 1:699–725

    Article  PubMed  CAS  Google Scholar 

  5. Reaven GM (1987) Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Am J Med 83 Suppl:3A:31–40

    Article  PubMed  CAS  Google Scholar 

  6. Kostner GM, Karádi I (1988) Lipoprotein alterations in diabetes mellitus. Diabetologia 31:717–22

    Article  PubMed  CAS  Google Scholar 

  7. Steiner G (1988) Diabetes and atherosclerosis. Metabolic links. Drugs 36 Suppl:3:22–6

    Google Scholar 

  8. Betteridge DJ (1989) Lipids, diabetes, and vascular disease: The time to act. Diabetic Med 6:195–218

    Article  PubMed  CAS  Google Scholar 

  9. Betteridge DJ (1989) Diabetes, lipoprotein metabolism and atherosclerosis. Br Med Bull 45:285–311

    PubMed  CAS  Google Scholar 

  10. Durrington PN (1989) Hyperlipidaemia: diagnosis and management. London: Butter-worth.

    Google Scholar 

  11. Orchard TJ (1990) Dyslipoproteinemia and Diabetes. Endocrinology and Metabolism Clinics Of North America 19:361–80

    PubMed  CAS  Google Scholar 

  12. Kasama T, Yoshino G, Iwatani I, Iwai M, Hatanki H, Kazumi T, Oimomi M, Baba S (1987) Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics. Atherosclerosis 63:263–6

    Article  PubMed  CAS  Google Scholar 

  13. Iwai M, Yoshino G, Matsushita M, Morita M, Matsuba K, Kazumi T, Baba S (1990) Abnormal lipoprotein composition in normolipidemic diabetic patients. Diabetes Care 13:792–6

    Article  PubMed  CAS  Google Scholar 

  14. Bagdade JD, Buchanan WE, Kuusi T, Taskinen M-R (1990) Persisent abnormalities in lipoprotein composition in noninsulin dependent diabetes after intensive insulin therapy. Arteriosclerosis 10:232–9

    Article  PubMed  CAS  Google Scholar 

  15. Barter PJ (1990) Enzymes involved in lipid and lipoprotein metabolism. Curr Opin Lipidol 1:518–23

    Article  Google Scholar 

  16. Brown MS, Goldstein JL (1990) Scavenging for receptors. Nature 343:508

    Article  PubMed  CAS  Google Scholar 

  17. Musliner TA, Krauss RM (1988) Lipoprotein subspecies and risk of coronary disease. Clin Chem 34:B78–83

    PubMed  CAS  Google Scholar 

  18. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S (1984) Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4:225–31

    Article  PubMed  CAS  Google Scholar 

  19. Taskinen M-R, Nikkilä EA (1981) High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man — evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. Clin Chim Acta 112:325–32

    Article  PubMed  CAS  Google Scholar 

  20. Clay MA, Rye K-A, Barter PJ (1990) Evidence in vitro that hepatic lipase reduces the concentration of apolipoprotein A-I in rabbit high-density lipoproteins. Biochim Biophys Acta 1044:50–6

    Article  PubMed  CAS  Google Scholar 

  21. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM (1983) Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 80:1449–53

    Article  PubMed  CAS  Google Scholar 

  22. Ginsberg H, Grundy SM (1982) Very low density lipoprotein metabolism in nonketotic diabetes mellitus: Effect of dietary restriction. Diabetologia 23:421–5

    Article  PubMed  CAS  Google Scholar 

  23. Greenfield M, Kolterman O, Olefsky J, Reaven GM (1980) Mechanism of hypertrigly-ceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 18:441–6

    Article  PubMed  CAS  Google Scholar 

  24. Taskinen M-R (1990) Hyperlipidaemia in diabetes. Baillière’s Clinical Endocrinology and Metabolism 4:743–75

    Article  PubMed  CAS  Google Scholar 

  25. Rivellese A, Riccardi G, Romano G, Giacco R, Patti L, Marotta G, Annuzzi G, Mancini M (1988) Presence of very low density lipoprotein compositional abnormalities in Type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation. Diabetologia 31:884–8

    Article  PubMed  CAS  Google Scholar 

  26. James RW, Pometta D (1990) Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes 39:1158–64

    Article  PubMed  CAS  Google Scholar 

  27. Klein RL, Lyons TJ, Lopes-Virella MF (1989) Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages. Metabolism 38:1108–14

    Article  PubMed  CAS  Google Scholar 

  28. Taskinen M-R, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, Howard BV (1986) Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipopro-tein B metabolism. Studies before and after sulfonylurea therapy. Diabetes 35:1268–77

    Article  PubMed  CAS  Google Scholar 

  29. Winocour PH, Durrington PN, Ishola M, Anderson DC (1986) Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet 1:1176–8

    Article  PubMed  CAS  Google Scholar 

  30. Winocour PH, Ishola M, Durrington PN (1989) Validation of the Friedewald formula for the measurement of low density lipoprotein cholesterol in insulin-dependent diabetes mellitus. Clin Chim Acta 179:79–83

    Article  PubMed  CAS  Google Scholar 

  31. Weisweiler P, Schwandt P (1987) Type 1 (insulin-dependent) versus Type 2 (non-insulin-dependent) diabetes mellitus: characterization of serum lipoprotein alterations. Eur J Clin Invest 17:87–91

    Article  PubMed  CAS  Google Scholar 

  32. Fielding CJ, Castro GR, Dormer C, Fielding PE, Reaven GM (1986) Distribution of Apolipoprotein E in the plasma of insulin-dependent and noninsulin-dependent diabetics and its relation to cholesterol net transport. J Lipid Res 27:1052–61.

    PubMed  CAS  Google Scholar 

  33. Eto M, Watanabe K, Iwashima Y, Morikawa A, Oshima E, Sekiguchi M, Ishii K (1986) Apolipoprotein E polymorphism and hyperlipemia in type II diabetes. Diabetes 35:1374–82

    Article  PubMed  CAS  Google Scholar 

  34. Eto M, Watanabe K, Sato T, Makino I (1989) Apolipoprotein-E2 and hyperlipoproteinemia in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:1207–12

    Article  PubMed  CAS  Google Scholar 

  35. Winocour PH, Tetlow L, Durrington PN, Hillier V, Anderson DC (1989) Apolipoprotein E polymorphism and lipoproteins in insulin treated diabetes mellitus. Atherosclerosis 75:167–73

    Article  PubMed  CAS  Google Scholar 

  36. Sano R, Abe R, Oikawa S, Fujii Y, Toyota T (1985) ApoE-2/E-3 ratio of very low density lipoprotein in diabetes mellitus. Tohoku J exp Med 146:131–6

    Article  PubMed  CAS  Google Scholar 

  37. Black S, Brunt RV, Reckless JPD (1985) Apolipoprotein E isoforms in diabetes. Monogr Atherosclerosis 13:111–4

    CAS  Google Scholar 

  38. McDowell IFW, Wisdom GB, Trimble ER (1989) Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin Chem 35:2070–3

    PubMed  CAS  Google Scholar 

  39. Zilversmit DB (1979) Atherogenesis: A postprandial phenomenon. Circulation 60:473–85

    Article  PubMed  CAS  Google Scholar 

  40. MBewu AD, Durrington PN (1990) Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85:1–14

    Article  PubMed  CAS  Google Scholar 

  41. Bruckert E, Davidoff P, Grimaldi A, Truffert J, Giral P, Doumith R, Thervet F, De-Gennes JL (1990) Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control (letter). JAMA 263:35–6

    Article  PubMed  CAS  Google Scholar 

  42. Miller NE (1987) Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113 2:Suppl:2:589–97

    Article  PubMed  CAS  Google Scholar 

  43. Reichl D, Miller NE (1989) Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 9:785–97

    Article  PubMed  CAS  Google Scholar 

  44. Lechleitner M, Misenböck G, Patsch JR (1990) HDL cholesterol, triglycerides and coronary heart disease. Curr Opin Lipidol 1:330–3

    Article  Google Scholar 

  45. Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH (1980) Hyperglycemia and plasma lipid levels: A prospective study of young insulin-dependent diabetic patients. N Engl J Med 302:650–4

    Article  PubMed  CAS  Google Scholar 

  46. Calvert GD, Mannik T, Graham JJ, Wise PH, Yeates RA (1978) Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet 2:66–8

    Article  PubMed  CAS  Google Scholar 

  47. Eckel RH, Albers JJ, Cheung MC, Wahl PW, Lindgren FT, Bierman EL (1981) High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes 30:132–8

    Article  PubMed  CAS  Google Scholar 

  48. Brunzell JD, Chait A, Bierman EL (1985) Plasma lipoproteins in human diabetes mellitus. In: Alberti KGGM (ed) The Diabetes Annual 1 pp 463–479 Elsevier Science Publishers BV

    Google Scholar 

  49. Mattock MB, Salter AM, Fuller JH, Omer T, R-El-Gohari, Redmond SD, Keen H (1982) High density lipoprotein subfractions in insulin-dependent diabetic and normal subjects. Atherosclerosis 45:67–79

    Article  PubMed  CAS  Google Scholar 

  50. Kennedy AL, Lappin TRJ, Lavery TD, Hadden DR, Weaver JA, Montgomery DAD (1978) Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control. Br Med J 2:1191–4

    Article  PubMed  CAS  Google Scholar 

  51. Semenkovich CF, Ostlund RE Jr, Schechtman KB (1989) Plasma lipids in patients with Type I diabetes mellitus. Influence of race, gender, and plasma glucose control: Lipids do not correlate with glucose control in black women. Arch Intern Med 149:51–6

    Article  PubMed  CAS  Google Scholar 

  52. Dunn FL, Pietri A, Raskin P (1981) Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus. Ann Intern Med 95:426–31

    PubMed  CAS  Google Scholar 

  53. Lopes-Virella MF, Wohltmann HJ, Mayfield RK, Loadholt CB, Colwell JA (1983) Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes 32:20–5

    PubMed  CAS  Google Scholar 

  54. Laakso M, Pyörälä K, Sarlund H, Voutilainen E (1986) Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus. Arteriosclerosis 6:679–84

    Article  PubMed  CAS  Google Scholar 

  55. Durrington PN (1982) High-density lipoprotein cholesterol: methods and clinical significance. Crit Rev Clin Lab Sci 18:31–78

    Article  PubMed  CAS  Google Scholar 

  56. Bagdade JD, Subbaiah PV (1989) Abnormal high-denisty lipoprotein composition in women with insulin-dependent diabetes. J Lab Clin Med 113:235–40

    PubMed  CAS  Google Scholar 

  57. Tertov W, Sobenin IA, Tonevitsky AG, Orekhov AN, Smornov VN (1990) Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: Separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Comm 167:1122–7

    Article  PubMed  CAS  Google Scholar 

  58. Hoak JC, Connor WE, Warner ED (1968) Toxic effects of glucagon-induced acute lipid mobilization in geese. J Clin Invest 47:2701–10

    Article  PubMed  CAS  Google Scholar 

  59. Curtiss LK, Witztum JL (1985) Plasma apolipoproteins A1, A11, B, C1, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 34:452–61

    Article  PubMed  CAS  Google Scholar 

  60. Taskinen M-R, Kahri J, Shepherd J, Packard CJ (1990) HDL Apoprotein A-1 and A-1 1 metabolism in IDDM. Diabetes 39 Suppl:1:63A

    Google Scholar 

  61. Nikkilä EA, Taskinen M-R, Sane T (1987) Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism. Am Heart J 113 2:Suppl:2:543–8

    Article  PubMed  Google Scholar 

  62. Bagdade JD, Subbaiah PV (1989) Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men. Diabetes 38:1226–30

    Article  PubMed  CAS  Google Scholar 

  63. Reckless JPD, Betteridge DJ, Wu P, Payne B, Galton DJ (1978) High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J 1:883–6

    Article  PubMed  CAS  Google Scholar 

  64. Beach KW, Brunzell JD, Conquest LL, Strandness DE (1979) The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and non-insulin-dependent diabetes. Diabetes 28:836–40

    PubMed  CAS  Google Scholar 

  65. Briones ER, Mao SJT, Palumbo PJ, O’Fallon WM, Chenoweth W, Kottke BA (1984) Analysis of plasma lipids and apolipoproteins in insulin-dependent and non-insulin-dependent diabetics. Metabolism 33:42–9

    Article  PubMed  CAS  Google Scholar 

  66. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN (1991) Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86:193–9

    Article  PubMed  CAS  Google Scholar 

  67. Greenfield MS, Doberne L, Rosenthal M, Vreman HJ, Reaven GM (1982) Lipid metabolism in non-insulin-dependent diabetes mellitus. Effect of glipizide therapy. Arch Intern Med 142:1498–500

    Article  PubMed  CAS  Google Scholar 

  68. Waiden CE, Knopp RH, Wahl PW, Beach KW, Strandness E Jr (1984) Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. New Engl J Med 311:953–9

    Article  Google Scholar 

  69. Laakso M, Voutilainen E, Sarlund H, Aro A, Pyörälä K, Penttilä I (1985) Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics. Atherosclerosis 56:271–81

    Article  PubMed  CAS  Google Scholar 

  70. Leowsky J, James RW, Taton J, Pometta D (1988) The influence of metabolic control on very low density lipoprotein composition in hypertriglyceridemic type II diabetics. A study using heparin-sepharose chromatography. Metabolism 37:721–6

    Article  PubMed  CAS  Google Scholar 

  71. Billingham MS, Milles JJ, Bailey CJ, Hall RA (1989) Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin. Metabolism 38:850–7

    Article  PubMed  CAS  Google Scholar 

  72. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN (1989) Insulin deficiency in non-insulin-dependent diabetes. Lancet 1:293–5

    Article  PubMed  CAS  Google Scholar 

  73. Reaven GM, Chen Y-Di (1988) Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes/Metabolism Reviews 4:639–52

    Article  PubMed  CAS  Google Scholar 

  74. Durrington PN, Newton RS, Weinstein DB, Steinberg D (1982) Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest 70:63–73

    Article  PubMed  CAS  Google Scholar 

  75. Patsch W, Franz S, Schonfeld G (1983) Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest 71:1161–74

    Article  PubMed  CAS  Google Scholar 

  76. Mangiapane EH, Brindley DN (1986) Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem J 233:155–60

    Google Scholar 

  77. Dashti N, Wolfbauer G (1987) Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res 28:423–36

    PubMed  CAS  Google Scholar 

  78. Shumak SL, Zinman B, Zuniga-Guarjardo S, Poapst M, Steiner G (1988) Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans. Metabolism 37:461–6

    Article  PubMed  CAS  Google Scholar 

  79. Abbott WGH, Lillioja S, Young AA, Zawadski JK, Yki-Järvinen H, Christin L, Howard BV (1987) Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 36:897–904

    Article  PubMed  CAS  Google Scholar 

  80. Laakso M, Sarlund H, Mykkänen L (1990) Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223–31

    Article  PubMed  CAS  Google Scholar 

  81. Kissebah AH, Adams PW, Wynn V (1974) Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin). Diabetologia 10:119–30

    Article  PubMed  CAS  Google Scholar 

  82. Howard BV, Reitman JS, Vasquez B, Zech L (1983) Very-low-density lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus. Diabetes 32:271–6

    Article  PubMed  CAS  Google Scholar 

  83. Howard BV, Abbott WGH, Beltz WF, Harper IT, Fields RM, Grundy SM, Taskinen M-R (1987) Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36:870–7

    Article  PubMed  CAS  Google Scholar 

  84. Howard BV, Abbott WGH, Egusa G, Taskinen M-R (1987) Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: Effects of obesity and non-insulin-dependent diabetes mellitus. Am Heart J 113:Suppl:2:522–6

    Article  PubMed  CAS  Google Scholar 

  85. Taskinen M-R, Nikkilä EA (1979) Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Diabetologia 17:351–6

    Article  PubMed  CAS  Google Scholar 

  86. Taskinen M-R, Nikkilä EA, Kuusi T, Harno K (1982) Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity. Diabetologia 22:46–50

    Article  PubMed  CAS  Google Scholar 

  87. Sadur CN, Eckel RH (1982) Insulin stimulation of adipose tissue lipoprotein lipase. J Clin Invest 69:1119–25

    Article  PubMed  CAS  Google Scholar 

  88. Farese RV, Yost TJ, Eckel RH (1991) Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 40:214–6

    Article  PubMed  CAS  Google Scholar 

  89. Taskinen M-R, Kuusi T, Helve E, Nikkilä EA, Yki-Järvinen H (1988) Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin-dependent diabetes. Arteriosclerosis 8:168–77

    Article  PubMed  CAS  Google Scholar 

  90. Agardh C-D, Nilsson-Ehle P, Scherstén B (1982) Improvement of the plasma lipoprotein pattern after institution of insulin treatment in diabetes mellitus. Diabetes Care 5:322–5

    Article  PubMed  CAS  Google Scholar 

  91. Taskinen M-R, Packard CJ, Shepherd J (1990) Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39:1017–27

    Article  PubMed  CAS  Google Scholar 

  92. Pfeifer MA, Brunzell JD, Best JD, Judzewitsch RG, Halter JB, Porte D Jr (1983) The response of plasma triglyceride cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes 32:525–31

    Article  PubMed  CAS  Google Scholar 

  93. Taskinen M-R (1987) Lipoprotein lipase in diabetes. Diabetes/Metabolism Reviews 3:551–70

    Article  PubMed  CAS  Google Scholar 

  94. Mamo JCL, Szeto L, Steiner G (1990) Glycation of very low density lipoprotein from rat plasma impairs its catabolism. Diabetologia 33:339–45

    Article  PubMed  CAS  Google Scholar 

  95. Fielding CJ, Reaven GM, Liu G, Fielding PE (1984) Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA 81:2512–6

    Article  PubMed  CAS  Google Scholar 

  96. Reaven GM (1987) Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism 36:Suppl:1:1–8

    Article  PubMed  CAS  Google Scholar 

  97. Kissebah AH, Alfarsi S, Evans DJ, Adams PW (1982) Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 31:217–25

    Article  PubMed  CAS  Google Scholar 

  98. Ginsberg HN (1987) Very low density lipoprotein metabolism in diabetes mellitus. Diabetes/Metabolism Reviews 3:571–89

    Article  PubMed  CAS  Google Scholar 

  99. Bradley WA, Hwang SLC, Karlin JB, Lin AHY, Prasad SC, Gotto AM Jr, Gianturco SH (1984) Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J Biol Chem 259:14728–35

    PubMed  CAS  Google Scholar 

  100. Gianturco SH, Bradley WA, Gotto AM, Morrisett JD, Peavy DL (1982) Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest 70:168–78

    Article  PubMed  CAS  Google Scholar 

  101. Reardon MF, Fidge NH, Nestel PJ (1978) Catabolism of very low density lipoprotein B apoprotein in man. J Clin Invest 61:850–60

    Article  PubMed  CAS  Google Scholar 

  102. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J (1990) Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 85:193–202

    Article  PubMed  CAS  Google Scholar 

  103. Uusitupa M, Siitonen O, Voutilainen E, Aro A, Hersio K, Pyörälä K, Penttilä I, Ehnholm C (1986) Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (Type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 9:17–22

    Article  PubMed  CAS  Google Scholar 

  104. Taskinen M-R, Hilden H, Syvänne M (1990) Postprandial lipemia and coronary artery disease (CAD) in type 2 (non-insulin dependent) diabetes. Diabetologia 33:Suppl:A203

    Google Scholar 

  105. Wang C-S, McConathy WJ, Kloer HU, Alaupovic P (1985) Modulation of lipoprotein lipase activity by apolipoproteins. J Clin Invest 75:384–90

    Article  PubMed  CAS  Google Scholar 

  106. Stalenhoef AFH, Demacker PNM, Lutterman JA, van’t Laar A (1982) Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia. Daibetologia 22:489–91

    Article  CAS  Google Scholar 

  107. Gomez JA, del Pozo C, Sorribas A, Serrat J, Gonzalez-Sastre F, de Leiva A (1989) Apolipoprotein C subtype distribution in type 2 diabetes mellitus. Diabetic Med 6:127–30

    Article  PubMed  CAS  Google Scholar 

  108. Gabor J, Spain M, Kalant N (1980) Composition of serum very-low-density and high-density lipoproteins in diabetes. Clin Chem 26:1261–5

    PubMed  CAS  Google Scholar 

  109. Weisweiler P, Drosner M, Schwandt P (1982) Dietary effects on very low-density lipoproteins in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 23:101–3

    Article  PubMed  CAS  Google Scholar 

  110. Pan XR, Cheung MC, Waiden CE, Hu SX, Bierman EL, Albers J (1986) Abnormal composition of apoproteins C-1, C-11 and C-111 in plasma and very-low-density lipoproteins of non-insulin-dependent diabetic Chinese. Clin Chem 32:1914–20

    PubMed  CAS  Google Scholar 

  111. Fielding CJ, Reaven GM, Fielding PE (1982) Human non-insulin-dependent diabetes: Identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E. Proc Natl Acad Sci USA 79:6365–9

    Article  PubMed  CAS  Google Scholar 

  112. Joven J, Vilella E, Costa B, Turner PR, Richart C, Masana L (1989) Concentration of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes. Clin Chem 35:813–6

    PubMed  CAS  Google Scholar 

  113. Haffner SM, Foster DM, Kushwaha RS, Hazzard WR (1984) Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin-dependent) diabetic subjects with lipaemia. Diabetologia 26:349–54

    Article  PubMed  CAS  Google Scholar 

  114. Barrett-Connor E, Grundy SM, Holdbrook MJ (1982) Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 115:657–63

    PubMed  CAS  Google Scholar 

  115. Kissebah AH (1987) Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Diabetes/Metabolism Reviews 3:619–51

    Article  PubMed  CAS  Google Scholar 

  116. Falko JM, Parr JH, Simpson RN, Wynn V (1987) Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med 83:641–7

    Article  PubMed  CAS  Google Scholar 

  117. Packard CJ, Munro A, Lorimer R, Gotto AM, Shepherd J (1984) Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 74:2178–92

    Article  PubMed  CAS  Google Scholar 

  118. Hiramatsu K, Bierman EL, Chait A (1985) Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts. Diabetes 34:8–14

    Article  PubMed  CAS  Google Scholar 

  119. Kim H-J, Kurup IV (1982) Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylation. Metabolism 31:348–53

    Article  PubMed  CAS  Google Scholar 

  120. Steinbrecher UP, Witztum JL (1984) Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33:130–4

    Article  PubMed  CAS  Google Scholar 

  121. Steinbrecher UP, Witztum JL, Kesaniemi YA, Elam RL (1983) Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism. J Clin Invest 71:960–4

    Article  PubMed  CAS  Google Scholar 

  122. Owens D, Maher V, Collins P, Johnson A, Tomkin G (1990) Cellular cholesterol regulation — a defect in the type 2 (non-insulin-dependent) diabetic patient in poor metabolic control. Diabetologia 33:93–9

    Article  PubMed  CAS  Google Scholar 

  123. Chait A, Bierman EL, Albers JJ (1979) Low-density lipoprotein receptor activity in cultured human skin fibroblasts. J Clin Invest 64:1309–19

    Article  PubMed  CAS  Google Scholar 

  124. Mazzone T, Foster D, Chait A (1984) In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 33:333–8

    Article  PubMed  CAS  Google Scholar 

  125. Wade DP, Knight BL, Soutar AK (1988) Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma Hep G2 cells. Eur J Biochem 174:213–8

    Article  PubMed  CAS  Google Scholar 

  126. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917–21

    Article  PubMed  CAS  Google Scholar 

  127. Kraemer FB, Chen Y-DI, Cheung RMC, Reaven GM (1982) Are the binding and degradation of low density lipoprotein altered in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 23:28–33

    Article  PubMed  CAS  Google Scholar 

  128. Fisher WR (1983) Heterogeneity of plasma low density lipoproteins; manifestations of the physiologic phenomenon in man. Metabolism 32:283–91

    Article  PubMed  CAS  Google Scholar 

  129. Suzuki N, Oikawa S, Hori S, Fujii Y, Sakuma E, Kotake H, Namai K, Yoshie K, Goto Y (1989) Appearance of multidisperse low density lipoprotein and altered lipoprotein composition in non-insulin-dependent diabetes with type IIa hyperlipoproteinemia. Metabolism 38:224–9

    Article  PubMed  CAS  Google Scholar 

  130. Austin MA, Krauss RM (1986) Genetic control of low-density-lipoprotein subclasses. Lancet 2:592–4

    Article  PubMed  CAS  Google Scholar 

  131. Riccardi G (1990) Hormones, diabetes mellitus and lipoprotein metabolism. Curr Opin Lipidol 1:237–43

    Article  Google Scholar 

  132. Taskinen M-R, Harno K, Nikkilä EA (1984) Serum lipids and lipoproteins in type 2 diabetes. Acta Endocrinol Suppl:262:95–9

    Google Scholar 

  133. Lopes-Virella MFL, Stone PG, Colwell JA (1977) Serum high density lipoprotein in diabetic patients. Diabetologia 13:285–91

    Article  PubMed  CAS  Google Scholar 

  134. Hollenbeck CB, Chen Y-DI, Greenfield MS, Lardinois CK, Reaven GM (1986) Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 62:605–8

    Article  PubMed  CAS  Google Scholar 

  135. Bergman M, Gidez LI, Eder HA (1986) High-density lipoprotein subclasses in diabetes. Am J Med 81:488–92

    Article  PubMed  CAS  Google Scholar 

  136. Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bassett ML, Bierman EL (1982) Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics. Diabetes 31:126–31

    PubMed  CAS  Google Scholar 

  137. Billingham MS, Milles JJ, Bailey CJ, Hall RA (1989) Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide. Diabetes Res 11:13–20

    PubMed  CAS  Google Scholar 

  138. Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett PH (1984) Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Arteriosclerosis 4:462–71

    Article  PubMed  CAS  Google Scholar 

  139. Golay A, Zech L, Shi M-Z, Chiou Y-AM, Reaven GM, Chen Y-DI (1987) High density lipoprotein (HDL) metabolism in non-insulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab 65:512–8

    Article  PubMed  CAS  Google Scholar 

  140. Chang LBF, Hopkins GJ, Barter PJ (1985) Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects. Atherosclerosis 56:61–70

    Article  PubMed  CAS  Google Scholar 

  141. Bittolo Bon G, Cazzolato G, Avogaro P (1984) Lipids, lipoproteins and apolipoproteins in type I and type II diabetes mellitus. Acta Diabetol Lat 21:315–24

    Article  PubMed  CAS  Google Scholar 

  142. Witztum JL, Fisher M, Pietro T, Steinbrecher UP, Elam RL (1982) Nonenzymatic glucosylation of high-density lipoprotein accelerates its catabolism in guinea pigs. Diabetes 31:1029–32

    Article  PubMed  CAS  Google Scholar 

  143. Schleicher E, Olgemöller B, Schön J, Dürst T, Wieland OH (1985) Limited nonenzymatic glucosylation of low-density lipoprotein does not alter its catabolism in tissue culture. Biochim Biophys Acta 846:226–33

    Article  PubMed  CAS  Google Scholar 

  144. Kesaniemi YA, Witztum JL, Steinbrecher UP (1983) Receptor-mediated catabolism of low density lipoprotein in man. J Clin Invest 71:950–9

    Article  PubMed  CAS  Google Scholar 

  145. Schleicher E, Deufel T, Wieland OH (1981) Non-enzymatic glycosylation of human serum lipoproteins. FEBS Lett 129:1–5

    Article  PubMed  CAS  Google Scholar 

  146. Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Virella MF (1986) Glycosylation of low density lipoprotein in patients with type I (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia 29:685–9

    Article  PubMed  CAS  Google Scholar 

  147. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL (1988) Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37:550–7

    Article  PubMed  CAS  Google Scholar 

  148. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–24

    Article  PubMed  CAS  Google Scholar 

  149. Laakso M, Pyörälä (1988) Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease. Atherosclerosis 74:55–63

    Article  PubMed  CAS  Google Scholar 

  150. Kita T, Nagano Y, Yokode M (1987) Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84:5928–31

    Article  PubMed  CAS  Google Scholar 

  151. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P (1991) The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arteriosclerosis 11:15–22

    Article  Google Scholar 

  152. Barnett PA, Gonzalez G, Chylack LT, Cheng HM (1986) The effect of oxidation on sorbitol pathway kinetics. Diabetes 35:426–32

    Article  PubMed  CAS  Google Scholar 

  153. Hiramatsu K, Arimori S (1988) Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 37:832–7

    Article  PubMed  CAS  Google Scholar 

  154. Wolff SP, Dean RT (1987) Glucose autoxidation and protein modification: the potential role of “autoxidative glycosylation” in diabetes. Biochem J 245:243–50

    PubMed  CAS  Google Scholar 

  155. Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Comm 173:932–9

    Article  PubMed  CAS  Google Scholar 

  156. Sagone ALJ, Greenwald J, Kraut EH, Bianchine J, Singh D (1983) Glucose: a role as a free radical scavenger in biological systems. J Lab Clin Med 101:97–104

    PubMed  Google Scholar 

  157. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K (1979) Lipid peroxide level in plasma of diabetic patients. Biochem Med 21:104–7

    Article  PubMed  CAS  Google Scholar 

  158. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K (1981) Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 25:373–8

    Article  PubMed  CAS  Google Scholar 

  159. Kaji H, Kurasaki M, Ito K, Saito T, Saito K, Niikola T, Kojima Y, Ohsaki Y, Ide H, Tsuji M, Kondo T, Kawakami Y (1985) Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin Wochenschr 63:765–8

    Article  PubMed  CAS  Google Scholar 

  160. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH (1987) Increased diene conjugates in diabetic subjects with microangiopathy. Diabetic Med 4:452–6

    Article  PubMed  CAS  Google Scholar 

  161. Collier A, Jackson M, Dawkes RM, Bell D, Clarke BF (1988) Reduced free radical activity detected by decreased diene conjugates in insulin-dependent diabetic patients. Diabetic Med 5:747–9

    Article  PubMed  CAS  Google Scholar 

  162. Stringer MD, Görög PG, Freeman A, Kakkar VV (1989) Lipid peroxides and atherosclerosis. Br Med J 298:281–4

    Article  CAS  Google Scholar 

  163. Karpen CW, Cataland S, O’Dorisio TM, Panganamala RV (1985) Production of 12-hydroxyeicosatetraenoic acid and vitamin E status in platelets from Type 1 human diabetic subjects. Diabetes 34:526–31

    Article  PubMed  CAS  Google Scholar 

  164. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC (1989) Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 298:487–90

    Article  CAS  Google Scholar 

  165. Dullaart RPF, Dikkeschei LD, Doorenbos H (1989) Alterations in serum lipids and apolipoproteins in male Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 32:685–9

    PubMed  CAS  Google Scholar 

  166. Allawi J, Jarrett RJ (1989) Microalbuminuria and cardiovascular risk factors in type 2 diabetes mellitus. Diabetic Med 7:115–8

    Article  Google Scholar 

  167. Austin MA, King M-C, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82:495–506

    Article  PubMed  CAS  Google Scholar 

  168. Crouse JR, Parks JS, Schey HM, Kahl FR (1985) Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566–75

    PubMed  CAS  Google Scholar 

  169. Baynes C, Feher MD, Elkeles RS (1989) The effect of treatment of non-insulin-dependent diabetes mellitus (NIDDM) on serum lipids and lipoproteins. Q J Med 72:579–87

    PubMed  CAS  Google Scholar 

  170. Winocour PH, Laker MF (1990) Drug therapy for diabetic dyslipoproteinaemia: a practical approach. Diabetic Med 7:292–8

    Article  PubMed  CAS  Google Scholar 

  171. Grundy S, Vega GL, Garg A (1990) Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia. Am J Cardiol 66:31B–8B

    Article  PubMed  CAS  Google Scholar 

  172. Garg A, Grundy SM (1990) Therapeutic perspectives in hyperlipidemic patients with diabetes mellitus. J Diabetic Complications 4:72–4

    Article  CAS  Google Scholar 

  173. Laakso M, Pyörälä K (1990) Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes. Metabolism 39:117–22

    Article  PubMed  CAS  Google Scholar 

  174. Fuessl HS, Williams G, Adrian TE, Bloom SR (1987) Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patients. Diabetic Med 4:463–8

    Article  PubMed  CAS  Google Scholar 

  175. Durrington PN, Winocour PH (1989) Therapeutic aspects of hyperlipidaemia in diabetes. Postgrad Med J 65 suppl:1:S33–41

    PubMed  Google Scholar 

  176. Taylor KG, John WG, Matthews KA, Wright AD (1982) A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes. Diabetologia 23:507–10

    Article  PubMed  Google Scholar 

  177. Verma SP, Philippot FR, Bonnet B, Rostain-Capaillon O, Sainte-Marie J, Colette C, Monier L (1990) Structural abnormality in LDL from diabetic patients as revealed by resonance raman spectroscopy. Diabetes 39:1451–6

    Article  PubMed  CAS  Google Scholar 

  178. Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Arrol S, Lalor BC, Anderson DC (1990) Double-blind placebo-controlled study of the effects of bezafibrate on blood lipids, lipoproteins, and fibrinogen in hyperlipidaemic type 1 diabetes mellitus. Diabetic Med 7:736–43

    Article  PubMed  CAS  Google Scholar 

  179. Bagdade JD, Buchanan WE, Levy RA, Subbaiah PV, Ritter MC (1990) Effects of w-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM. Diabetes 39:426–31

    Article  PubMed  CAS  Google Scholar 

  180. Mori TA, Vandongen R, Masarei JRL (1990) Fish oil-induced changes in apolipoproteins in IDDM subjects. Diabetes Care 13:725–32

    Article  PubMed  CAS  Google Scholar 

  181. Garg A, Grundy SM (1988) Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. N Engl J Med 318:81–6

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Elisabeth R. Trimble
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ian F. W. McDowell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Queen’s University of Belfast, Belfast, Northern Ireland, UK

    Robert W. Stout (Professor of Geriatric Medicine and Dean of the Faculty of Medicine) (Professor of Geriatric Medicine and Dean of the Faculty of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Trimble, E.R., McDowell, I.F.W. (1992). Lipid Metabolism and its Disorders in Diabetes Mellitus. In: Stout, R.W. (eds) Diabetes and Atherosclerosis. Developments in Cardiovascular Medicine, vol 125. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2734-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-2734-9_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5212-2

  • Online ISBN: 978-94-011-2734-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation